…
Nano Mobile Healthcare, Inc. operates as a mobile health technology company in the United States. The company develops personalized and point-of-care screening using applications based upon chemical sensing methods. It has a strategic partnership with Theranostics Laboratory, a translational research company. The company was formerly known as Vantage mHealthcare, Inc. and changed its name to Nano Mobile Healthcare, Inc. in September 2015. Nano Mobile Healthcare, Inc. was incorporated in 2010 and is based in Boston, Massachusetts. Nano Mobile Healthcare, Inc. is a subsidiary of Nanobeak, LLC.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Nano Mobile Healthcare Inc (VNTH) is a microcap listed on the OTC Pink market but provides limited recent public disclosures. The company states a focus on mobile healthcare, which may benefit from long-term digital health adoption and could attract speculative investors despite the information gap.
Material risks include lack of transparent financial reporting, very low trading liquidity and high volatility, execution and financing uncertainty, and regulatory/compliance risk.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 | 2012-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 | 2012-06-30 |
| Income before tax | -4.60M | 1.63M | -7.63M | -0.05M | - |
| Minority interest | - | - | - | -0.31M | - |
| Net income | -4.60M | 1.63M | -7.91M | -0.14M | - |
| Selling general administrative | 1.69M | 2.32M | 5.77M | 0.04M | 0.25M |
| Gross profit | 0.00M | -0.13M | -0.85M | 0.00M | - |
| Ebit | -1.69M | -2.46M | -6.63M | -0.06M | - |
| Operating income | -1.69M | -2.46M | -6.63M | -0.06M | - |
| Interest expense | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Net interest income | -2.47M | - | - | - | - |
| Non recurring | - | 0.13M | 0.85M | - | - |
| Income tax expense | 0.00M | 0.00M | 0.00M | 0.00M | - |
| Total revenue | 0.00M | 0.00M | 0.00M | 0.00M | - |
| Total operating expenses | 1.69M | 2.46M | 6.63M | 0.06M | - |
| Cost of revenue | 0.00M | 0.13M | 0.85M | 0.00M | - |
| Total other income expense net | -0.44M | 4.09M | -1.00M | 0.01M | - |
| Discontinued operations | - | - | -0.28M | -0.17M | - |
| Net income from continuing ops | -4.60M | 1.63M | -7.63M | -0.05M | - |
| Net income applicable to common shares | -4.60M | 1.63M | -7.91M | -0.14M | - |
| Breakdown | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 | 2012-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 | 2012-06-30 |
| Total assets | 0.01M | 0.30M | 0.40M | 0.10M | 0.32M |
| Other current assets | 0.00M | 0.04M | 0.14M | - | - |
| Total liab | 6.15M | 3.76M | 1.07M | 0.59M | 0.69M |
| Total stockholder equity | -6.14M | -3.46M | -0.67M | -0.19M | - |
| Other current liab | 2.95M | 2.49M | 0.66M | 0.56M | - |
| Common stock | 0.23M | 0.02M | 0.19M | 0.08M | 0.08M |
| Retained earnings | -11.57M | -6.97M | -8.61M | -0.70M | - |
| Other liab | - | - | - | - | 0.64M |
| Other assets | - | - | - | 0.10M | - |
| Cash | 0.00M | 0.25M | 0.24M | 0.09M | 0.30M |
| Total current liabilities | 6.15M | 3.60M | 0.85M | 0.59M | 0.05M |
| Short term debt | 2.63M | 0.90M | 0.29M | 0.56M | - |
| Short long term debt | 2.63M | 0.90M | 0.29M | 0.56M | - |
| Other stockholder equity | - | - | - | 0.16M | - |
| Property plant equipment | 0.01M | 0.01M | - | 0.01M | 0.01M |
| Total current assets | 0.00M | 0.29M | 0.38M | - | - |
| Long term investments | 0.00M | 0.00M | 0.02M | - | - |
| Net tangible assets | -6.17M | -3.46M | -0.67M | -0.19M | - |
| Long term debt | 0.00M | 0.16M | 0.22M | - | - |
| Accounts payable | 0.57M | 0.37M | 0.11M | 0.04M | 0.05M |
| Preferred stock total equity | 0.02M | - | - | - | - |
| Non currrent assets other | 0.00M | - | - | - | - |
| Non current assets total | 0.01M | - | - | - | - |
| Breakdown | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 | 2012-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 | 2012-06-30 |
| Investments | 0.00M | - | - | - | - |
| Change to liabilities | 0.21M | 0.26M | 0.08M | -0.02M | 0.00M |
| Total cashflows from investing activities | - | -0.01M | 0.01M | 0.01M | - |
| Net borrowings | 1.34M | 1.83M | 0.27M | -0.40M | - |
| Total cash from financing activities | 1.34M | 1.83M | 2.08M | -0.07M | 0.48M |
| Change to operating activities | 0.04M | 0.15M | -0.14M | -0.14M | - |
| Net income | -4.60M | 1.63M | -7.91M | -0.14M | - |
| Change in cash | -0.25M | 0.01M | 0.15M | 0.15M | - |
| Total cash from operating activities | -1.59M | -1.81M | -1.77M | -0.03M | - |
| Depreciation | 0.00M | 0.00M | 0.00M | 0.00M | - |
| Other cashflows from investing activities | - | - | 0.01M | 0.01M | - |
| Sale purchase of stock | - | - | 2.37M | 2.37M | - |
| Other cashflows from financing activities | - | 0.01M | -0.56M | 0.34M | - |
| Change to netincome | 0.45M | -4.35M | 6.18M | 0.13M | - |
| Capital expenditures | 0.00M | 0.01M | 0.01M | 0.01M | 0.01M |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|
| VNTH Nano Mobile Healthcare Inc |
- -% |
0.00 | - | - | - | - | -1.00 |
| VEEV Veeva Systems Inc Class A |
-6.78 2.21% |
300.22 | 43.49 | 29.59 | 12.48 | 5.79 | 33.41 |
| PMCUF Pro Medicus Limited |
- -% |
132.14 | 64.90 | 90.91 | 49.11 | 38.05 | 83.47 |
| TEM Tempus AI, Inc. Class A Common Stock |
2.22 2.83% |
80.70 | - | - | 8.68 | 25.39 | - |
| MTHRY M3 Inc |
-0.05 0.86% |
5.75 | 31.84 | 26.25 | 0.05 | 4.60 | 0.12 |
Nano Mobile Healthcare, Inc. operates as a mobile health technology company in the United States. The company develops personalized and point-of-care screening using applications based upon chemical sensing methods. It has a strategic partnership with Theranostics Laboratory, a translational research company. The company was formerly known as Vantage mHealthcare, Inc. and changed its name to Nano Mobile Healthcare, Inc. in September 2015. Nano Mobile Healthcare, Inc. was incorporated in 2010 and is based in Boston, Massachusetts. Nano Mobile Healthcare, Inc. is a subsidiary of Nanobeak, LLC.
| Name | Title | Year Born |
|---|---|---|
| Mr. Adam Matruski | Pres & CEO | NA |
| Mr. Robert J. Chicoski | CFO & Director | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.